Atlas Trials

Thromboembolic Risk Screening in Patients With Cancer and COVID-19

Clinical trial NCT04616846 · COMPLETED

Trial details

NCT number
NCT04616846
Sponsor
Centre Antoine Lacassagne
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Neoplasms MalignantCovid19Thromboembolism
Start date
2020-08-04
Primary completion
2022-01-25
Enrollment
88

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.